BiotechTube
Home/STALICLA/Lynn Durham
LD

Lynn Durham

Founder & CEO

STALICLA

Therapeutic Areas

Neurodevelopmental DisordersAutism Spectrum DisorderBrain Disorders

STALICLA Pipeline

DrugIndicationPhase
STP1Autism Spectrum Disorder (specific subgroup)Phase 2
STP2Autism Spectrum Disorder (specific subgroup)Preclinical

Leadership Team at STALICLA

DC
Dr. Carina R. Bichsel
Chief Operating Officer
DC
Dr. Carine de Beaufort
Chief Medical Officer
DP
Dr. Paul Wang
Head of Development
View full STALICLA profile